phenytoin has been researched along with Cardiovascular Diseases in 18 studies
Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Twenty-nine complications were burning pain at the IV site, and 36 were related to excessive total dose of phenytoin and resultant drug intoxication." | 5.27 | Complications of intravenous phenytoin for acute treatment of seizures. Recommendations for usage. ( Drury, LR; Earnest, MP; Marx, JA, 1983) |
| "After excluding patients in the monotherapy group with vascular etiology or previous cardiovascular events, in the remaining 400 patients, enzyme-inducer AEDs (EIAEDs), especially phenytoin (PHT), were associated with higher prevalence of dyslipidemia (PRa 1." | 3.85 | Prevalence of cardiovascular risk factors in people with epilepsy. ( Díez, L; Elosua, R; Gomez, A; Moreira, A; Roquer, J; Vivanco-Hidalgo, RM, 2017) |
| "From April 8, 1982, through June 1984, 11 patients in a single hospital experienced 17 episodes of limb edema and discoloration after the intravenous (IV) administration of phenytoin sodium (Dilantin)." | 3.67 | Severe soft-tissue injury following intravenous infusion of phenytoin. Patient and drug administration risk factors. ( Arrowsmith, JB; Buchanan, C; Graham, DR; Kilarski, DJ; Spengler, RF; Von Behren, L, 1988) |
| "To determine the adequacy of seizure control and the adverse effects of administering an IV loading dose of phenytoin by constant infusion pump." | 2.67 | Phenytoin administration by constant intravenous infusion: selective rates of administration. ( Cline, D; Donovan, PJ, 1991) |
| "Phenytoin is an established drug in the treatment of acute repetitive seizures and status epilepticus." | 2.53 | Cardiovascular adverse effects of phenytoin. ( Guldiken, B; Noachtar, S; Rémi, J, 2016) |
| "Harmine is a β-carboline alkaloid that displays antidepressant, antitumor and other pharmacological effects." | 1.62 | Central inhibition prevents the in vivo acute toxicity of harmine in mice. ( Gao, S; Li, J; Li, X; Liang, H; Lv, Y; Tang, X; Wang, M; Xiao, L; Zhang, J; Zou, H, 2021) |
| "Twenty-nine complications were burning pain at the IV site, and 36 were related to excessive total dose of phenytoin and resultant drug intoxication." | 1.27 | Complications of intravenous phenytoin for acute treatment of seizures. Recommendations for usage. ( Drury, LR; Earnest, MP; Marx, JA, 1983) |
| "Phenytoin plasma levels were measured by gas chromatography for up to 48 hours after dosing." | 1.26 | Phenytoin toxicity and blood levels after a large oral dose. ( Evens, RP; Fraser, DG; Ludden, TM; Sutherland, EW, 1980) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (66.67) | 18.7374 |
| 1990's | 3 (16.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (11.11) | 24.3611 |
| 2020's | 1 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Lv, Y | 1 |
| Liang, H | 1 |
| Li, J | 1 |
| Li, X | 1 |
| Tang, X | 1 |
| Gao, S | 1 |
| Zou, H | 1 |
| Zhang, J | 1 |
| Wang, M | 1 |
| Xiao, L | 1 |
| Guldiken, B | 1 |
| Rémi, J | 1 |
| Noachtar, S | 1 |
| Vivanco-Hidalgo, RM | 1 |
| Gomez, A | 1 |
| Moreira, A | 1 |
| Díez, L | 1 |
| Elosua, R | 1 |
| Roquer, J | 1 |
| Harned, HS | 1 |
| Mack, RB | 1 |
| Earnest, MP | 1 |
| Marx, JA | 1 |
| Drury, LR | 1 |
| Drake, CE | 1 |
| Evens, RP | 1 |
| Fraser, DG | 1 |
| Ludden, TM | 1 |
| Sutherland, EW | 1 |
| Quinn, MJ | 1 |
| Fitzgerald, DJ | 1 |
| Deglin, SM | 1 |
| Deglin, JM | 1 |
| Chung, EK | 1 |
| Ziegler, DK | 1 |
| Meran, A | 1 |
| Pfaltz, CR | 1 |
| Donovan, PJ | 1 |
| Cline, D | 1 |
| Wyte, CD | 1 |
| Berk, WA | 1 |
| Spengler, RF | 1 |
| Arrowsmith, JB | 1 |
| Kilarski, DJ | 1 |
| Buchanan, C | 1 |
| Von Behren, L | 1 |
| Graham, DR | 1 |
| Muuronen, A | 1 |
| Kaste, M | 1 |
| Nikkilä, EA | 1 |
| Tolppanen, EM | 1 |
| Raisfeld, IH | 1 |
6 reviews available for phenytoin and Cardiovascular Diseases
| Article | Year |
|---|---|
Cardiovascular adverse effects of phenytoin.
Topics: Anticonvulsants; Cardiovascular Diseases; Cardiovascular System; Humans; Phenytoin | 2016 |
Cardiovascular problems of the newborn and their etiologies.
Topics: Amphetamines; Animals; Cardiovascular Diseases; Estrogens; Ethanol; Female; Fetal Hypoxia; Heart Def | 1983 |
Ticlopidine and clopidogrel.
Topics: Adenosine Diphosphate; Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Angina, Unstable; Aspirin; Bo | 1999 |
Drug-induced cardiovascular diseases.
Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Antidepressive Agents, Tricyclic; Antihypertensive A | 1977 |
Toxicity to the nervous system of diphenylhydantoin: a review.
Topics: Adrenal Cortex Hormones; Animals; Cardiovascular Diseases; Cerebellar Ataxia; Cerebellar Diseases; C | 1978 |
Clinical pharmacology of drug interactions.
Topics: Antihypertensive Agents; Blood Coagulation Disorders; Cardiovascular Diseases; Coumarins; Drug Inter | 1973 |
1 trial available for phenytoin and Cardiovascular Diseases
| Article | Year |
|---|---|
Phenytoin administration by constant intravenous infusion: selective rates of administration.
Topics: Adult; Aged; Aged, 80 and over; Arteriosclerosis; Blood Pressure; Cardiovascular Diseases; Female; H | 1991 |
11 other studies available for phenytoin and Cardiovascular Diseases
| Article | Year |
|---|---|
Central inhibition prevents the in vivo acute toxicity of harmine in mice.
Topics: Acetylcholinesterase; Anesthetics; Animals; Cardiovascular Diseases; Central Nervous System Diseases | 2021 |
Prevalence of cardiovascular risk factors in people with epilepsy.
Topics: Adult; Aged; Anticonvulsants; Cardiovascular Diseases; Comorbidity; Dyslipidemias; Epilepsy; Female; | 2017 |
Medical exorcism--acute dilantin intoxication.
Topics: Cardiovascular Diseases; Epilepsy; Humans; Kinetics; Nystagmus, Pathologic; Phenytoin | 1984 |
Cardiovascular complications of TCA overdose.
Topics: Antidepressive Agents, Tricyclic; Bretylium Tosylate; Cardiovascular Diseases; Dobutamine; Humans; P | 1984 |
Complications of intravenous phenytoin for acute treatment of seizures. Recommendations for usage.
Topics: Adolescent; Adult; Aged; Cardiovascular Diseases; Crystallization; Female; Humans; Infusions, Parent | 1983 |
Cardiac drug overdose.
Topics: Arrhythmias, Cardiac; Bretylium Compounds; Cardiovascular Agents; Cardiovascular Diseases; Digoxin; | 1982 |
Phenytoin toxicity and blood levels after a large oral dose.
Topics: Adult; Blood Proteins; Cardiovascular Diseases; Gastrointestinal Diseases; Humans; Kinetics; Male; N | 1980 |
[The acute vestibular paralysis (author's transl)].
Topics: Adolescent; Adult; Aged; Amphetamines; Audiometry; Bacterial Infections; Cardiovascular Diseases; Ch | 1975 |
Severe oral phenytoin overdose does not cause cardiovascular morbidity.
Topics: Administration, Oral; Adult; Cardiovascular Diseases; Drug Overdose; Electrocardiography; Female; He | 1991 |
Severe soft-tissue injury following intravenous infusion of phenytoin. Patient and drug administration risk factors.
Topics: Age Factors; Aged; Cardiovascular Diseases; Catheterization; Connective Tissue Diseases; Edema; Fema | 1988 |
Mortality from ischaemic heart disease among patients using anticonvulsive drugs: a case-control study.
Topics: Aged; Anticonvulsants; Barbiturates; Carbamazepine; Cardiovascular Diseases; Cerebrovascular Disorde | 1985 |